X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (351) 351
Publication (28) 28
Book Chapter (6) 6
Book Review (4) 4
Data Set (1) 1
Dissertation (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (226) 226
maroteaux-lamy syndrome (192) 192
maroteaux-lamy-syndrome (166) 166
index medicus (152) 152
mucopolysaccharidosis (146) 146
enzyme replacement therapy (121) 121
female (110) 110
genetics & heredity (110) 110
male (110) 110
enzymes (85) 85
child (82) 82
medicine, research & experimental (79) 79
adolescent (67) 67
animals (66) 66
glycosaminoglycans (66) 66
child, preschool (64) 64
n-acetylgalactosamine 4-sulfatase (61) 61
mucopolysaccharidosis type vi (58) 58
enzyme-replacement therapy (57) 57
pediatrics (57) 57
biochemistry & molecular biology (55) 55
adult (53) 53
diagnosis (53) 53
bone-marrow-transplantation (51) 51
n-acetylgalactosamine-4-sulfatase - genetics (47) 47
mucopolysaccharidosis vi (45) 45
endocrinology & metabolism (44) 44
mucopolysaccharidosis vi - genetics (44) 44
disease (43) 43
care and treatment (39) 39
children (38) 38
mutation (37) 37
n-acetylgalactosamine-4-sulfatase (36) 36
lysosomal storage diseases (35) 35
mucopolysaccharidosis vi - therapy (35) 35
arylsulfatase b (34) 34
health aspects (34) 34
mucopolysaccharidosis vi - drug therapy (34) 34
phenotype (34) 34
transplantation (34) 34
maroteaux–lamy syndrome (33) 33
mucopolysaccharidosis vi - pathology (33) 33
treatment outcome (33) 33
mps vi (32) 32
mucopolysaccharidosis vi - diagnosis (31) 31
n-acetylgalactosamine-4-sulfatase - therapeutic use (31) 31
infant (30) 30
mucopolysaccharidoses (30) 30
ophthalmology (29) 29
young adult (29) 29
disease models, animal (28) 28
mucopolysaccharidosis vi - complications (28) 28
recombinant proteins - therapeutic use (28) 28
cats (27) 27
analysis (26) 26
galsulfase (25) 25
genetics (25) 25
lysosomal storage disorders (25) 25
medicine & public health (25) 25
surgery (25) 25
arylsulfatase-b (24) 24
hurler-syndrome (24) 24
identification (24) 24
glycosaminoglycans - urine (23) 23
mucopolysaccharidosis vi - enzymology (22) 22
patients (22) 22
expression (21) 21
genetic aspects (21) 21
glycosaminoglycans - metabolism (21) 21
mucopolysaccharidoses - complications (21) 21
research (21) 21
management (20) 20
mucopolysaccharidosis type-vi (20) 20
follow-up studies (19) 19
medical research (19) 19
medicine (19) 19
mucopolysaccharidosis vi - physiopathology (19) 19
stem-cell transplantation (19) 19
sulfatase (19) 19
arylsulfatase (18) 18
arylsulfatase-b gene (18) 18
feline model (18) 18
glycosaminoglycan (18) 18
hematopoietic stem cells (18) 18
internal medicine (18) 18
mice (18) 18
review (18) 18
arylsulfatase-b deficiency (17) 17
deficiency (17) 17
disease progression (17) 17
gene therapy (17) 17
human arylsulfatase-b (17) 17
medicine, experimental (17) 17
mucopolysaccharidoses - therapy (17) 17
n-acetylgalactosamine-4-sulfatase - metabolism (17) 17
sulfates (17) 17
enzyme replacement therapy - methods (16) 16
human genetics (16) 16
alleles (15) 15
article (15) 15
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (334) 334
Polish (6) 6
German (5) 5
French (3) 3
Portuguese (3) 3
Spanish (2) 2
Italian (1) 1
Russian (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


American Journal of Medical Genetics Part A, ISSN 1552-4825, 08/2014, Volume 164, Issue 8, pp. 1953 - 1964
Mucopolysaccharidosis VI (MPS VI) is a clinically heterogeneous and progressive disorder with multiorgan manifestations caused by deficient... 
multicenter study [publication type] | Maroteaux–Lamy syndrome | enzyme replacement therapy | respiratory function tests | N‐acetylgalactosamine‐4‐sulfatase | mucopolysaccharidosis VI | survival rate | exercise tolerance | follow‐up studies | Enzyme replacement therapy | Mucopolysaccharidosis VI | Exercise tolerance | Maroteaux-Lamy syndrome | N-acetylgalactosamine-4-sulfatase | Multicenter study [publication type] | Survival rate | Follow-up studies | Respiratory function tests | QUALITY | ENDURANCE | 6-MINUTE WALK TEST | INVOLVEMENT | DISORDERS | CHILDREN | ENZYME-REPLACEMENT THERAPY | follow-up studies | GENETICS & HEREDITY | EXPERIENCE | DISEASE PROGRESSION | AGE | N-Acetylgalactosamine-4-Sulfatase - therapeutic use | Recombinant Proteins - therapeutic use | Enzyme Replacement Therapy | Cross-Sectional Studies | Follow-Up Studies | Mucopolysaccharidosis VI - urine | Humans | Child, Preschool | Male | N-Acetylgalactosamine-4-Sulfatase - urine | Young Adult | Exercise Test | Mucopolysaccharidosis VI - mortality | Recombinant Proteins - urine | Adolescent | Quality of Life | Female | Mucopolysaccharidosis VI - drug therapy | Respiratory Function Tests | Child | Heart Function Tests | Body Weights and Measures | Surveys | Heart | Enzymes | Medical research | Glycosaminoglycans | Mortality | Medicine, Experimental | Development and progression | Mucopolysaccharidosis | Drug therapy | Age | N-Acetylgalactosamine-4-Sulfatase | Exercise Tolerance | Multicenter Study [Publication Type] | MeSH | Survival Rate
Journal Article
Annals of maxillofacial surgery, ISSN 2231-0746, 07/2017, Volume 7, Issue 2, pp. 282 - 286
Maroteaux-Lamy syndrome is one of the genetic disorders involving disturbances in mucopolysaccaride metabolism, due to deficiency of aryl sulfatase-B which... 
Physiological aspects | Medicine, Experimental | Medical research | Sulfates | Genetic disorder | Maroteaux–Lamy syndrome | multiple dentigerous cysts | Case Report
Journal Article
Journal Article
Journal Article
Molecular Genetics and Metabolism, ISSN 1096-7192, 09/2017, Volume 122, Issue 1-2, pp. 107 - 112
Journal Article
Genetics and Molecular Biology, ISSN 1415-4757, 2010, Volume 33, Issue 4, pp. 589 - 604
Journal Article
Drug Design, Development and Therapy, ISSN 1177-8881, 04/2015, Volume 9, pp. 1937 - 1953
Patients with mucopolysaccharidosis IVA (MPS IVA) can present with systemic skeletal dysplasia, leading to a need for multiple orthopedic surgical procedures,... 
Mucopolysaccharidosis IVA | Skeletal dysplasia | HSCT | ERT | Keratan sulfate | HURLER-SYNDROME | CHEMISTRY, MEDICINAL | mucopolysaccharidosis IVA | BONE-MARROW-TRANSPLANTATION | DRUG-DELIVERY SYSTEM | MUCOPOLYSACCHARIDOSIS TYPE-IVA | LYSOSOMAL STORAGE DISORDERS | II HUNTER-SYNDROME | skeletal dysplasia | MAROTEAUX-LAMY-SYNDROME | keratan sulfate | RECOMBINANT N-ACETYLGALACTOSAMINE-6-SULFATE SULFATASE | TERM-FOLLOW-UP | PHARMACOLOGY & PHARMACY | Hematopoietic Stem Cell Transplantation | Enzyme Replacement Therapy | Mucopolysaccharidosis IV - therapy | Humans | Enzymes | Care and treatment | Patient outcomes | Mucopolysaccharidosis | Transplantation | Health aspects | Hematopoietic stem cells | Methods | Heart | Therapy | Pediatrics | N-Acetylgalactosamine | Respiratory function | Deformation | Syngeneic grafts | Genotype & phenotype | Microorganisms | Apnea | Wheelchairs | Bone marrow | Bone dysplasia | Biocompatibility | Trochanter | Activities of daily living | Orthoses | Knee (anatomy) | Patients | Heart valves | Quality of life | Radiography | Pathology | Storage | Radiographs | Stem cells | Chondrocytes | Biomarkers | Scientific imaging | Mass spectrometry | Knee | Yeast | Transplants & implants | Medical services | Bone marrow transplantation | Stem cell transplantation | Pichia pastoris | Sulfates | Sleep disorders | Biomedical materials | Reduction | Skeleton | Lesions | Recombinant | Bone lesions | Medical screening | Chromatography | Hip | Hemopoiesis | Ankle | Lungs | Coronary vessels | Climb | Bone mineral density
Journal Article